StockVS

M Evo Global Acquisition Corp II (MEVOU) Analyse boursière

Services Financiers

M Evo Global Acquisition Corp II

$10.10

+$0.04 (+0.40%)

Dernière mise à jour : 26 mai 2026

Historique des Prix

Analyse

Présentation de l'entreprise

M Evo Global Acquisition Corp II operates within the financial services sector, specifically functioning as a shell company dedicated to executing a business combination through mergers, amalgamations, share exchanges, asset acquisitions, or reorganizations with one or more businesses. This operational model positions the entity as a special purpose acquisition company (SPAC) seeking to merge with a target business rather than generating organic revenue streams typical of operating companies. The company was incorporated in 2025 and maintains its headquarters in Farmers Branch, Texas, reflecting its recent establishment within the United States market. Regarding its scale, the market capitalization is listed as not available, annual revenue is not available, and the employee count is not available, which collectively indicates that the firm is in a pre-combination or transitional phase where traditional size metrics have not yet been established or disclosed to public record.

Santé financière

The financial statements for the trailing twelve months report a net income of $-119,861, while both revenue and EBITDA figures are not available. The significant negative net income in the absence of reported revenue highlights a cost structure where operating expenses, likely related to SPAC maintenance costs or deal expenses, exceed any minimal or unreported revenue generation, resulting in a net loss. Free cash flow is not available, which prevents an assessment of the company's immediate financial flexibility to fund ongoing operations or pursue a target without external financing. All three key margins—gross margin, operating margin, and profit margin—are recorded at 0.0%, indicating that the company is currently not generating profit from its operations or that revenue is insufficient to cover costs. On the balance sheet, total cash is not available, but total debt stands at $10, resulting in a debt-to-equity ratio of 0.06. This low leverage ratio suggests a conservative capital structure with minimal debt obligations relative to equity, though the lack of cash data obscures the full picture of liquidity management. The current ratio is 0.11, which signals a potential liquidity constraint where current liabilities exceed current assets, suggesting the company may face challenges meeting short-term obligations without additional capital. Return on equity and return on assets are both not available, making it impossible to evaluate management effectiveness in generating returns from shareholders' capital or total assets at this stage of the company's lifecycle.

Évaluation de la valorisation

The trailing P/E ratio and forward P/E ratio are both not available, rendering any comparison between current earnings and future expectations impossible due to the lack of positive earnings data. The price-to-book ratio is -3336.67, an extreme negative figure that indicates the market is pricing the company significantly below its book value, a common characteristic for shell companies with no tangible assets or operations yet. Price-to-sales ratio and EV/EBITDA multiples are also not available, meaning alternative valuation metrics cannot be utilized to determine fair value relative to revenue or cash flow generation. The stock has traded between a 52-week low of $10.01 and a 52-week high of $10.50, with the current trading price situated within this narrow range, reflecting the volatility typical of pre-merger entities where the share price is often pegged near the trust value. The beta value is not available, which precludes a quantitative analysis of the stock's price volatility relative to the broader market movements, although the narrow trading range suggests limited price fluctuation recently.

Growth & Income

Revenue growth year-over-year and earnings growth year-over-year are both not available, preventing an analysis of whether earnings are growing faster or slower than revenue. Since the company does not pay dividends, the dividend yield and payout ratio are not available, and the entity reinvests its limited resources into the search for a merger target rather than distributing income to shareholders. The overall growth and income profile is characterized by a complete absence of historical growth data and income distribution, typical for a shell company in its initial phase of existence.

Comparaison avec les pairs

M Evo Global Acquisition Corp II (MEVOU) opère dans le secteur Sociétés Écrans. Voici comment il se compare à ses pairs les plus proches par capitalisation boursière :

Entreprise Ticker Cap. Boursière Ratio P/E
M Evo Global Acquisition Corp II MEVOU N/A N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

Le ratio P/E moyen du secteur Sociétés Écrans est de 82.8x. M Evo Global Acquisition Corp II se négocie à un P/E de N/A.

Cette analyse est générée par IA à titre informatif uniquement et ne constitue pas un conseil financier. Les données peuvent être retardées ou inexactes. Faites toujours vos propres recherches et consultez un conseiller financier qualifié avant de prendre des décisions d'investissement.

À propos de M Evo Global Acquisition Corp II

M Evo Global Acquisition Corp II focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2025 and is headquartered in Farmers Branch, Texas.

La description de l'entreprise est affichée en anglais.

Statistiques Clés

Capitalisation
N/A
Ratio P/E
N/A
Plus Haut 52 Sem.
$10.50
Plus Bas 52 Sem.
$10.01
Volume Moyen
8.97K

Données fournies par Yahoo Finance via yfinance. Mis à jour quotidiennement.

Info Entreprise

Bourse
NASDAQ
Pays
United States